Danaher Corporation (DAP.DE)
- Previous Close
230.00 - Open
228.85 - Bid 229.55 x --
- Ask 229.95 x --
- Day's Range
225.75 - 230.50 - 52 Week Range
172.40 - 240.95 - Volume
282 - Avg. Volume
583 - Market Cap (intraday)
170.728B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
45.46 - EPS (TTM)
5.07 - Earnings Date Jul 23, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.01 (0.44%)
- Ex-Dividend Date Mar 27, 2024
- 1y Target Est
--
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
www.danaher.com61,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DAP.DE
Performance Overview: DAP.DE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DAP.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DAP.DE
Valuation Measures
Market Cap
170.25B
Enterprise Value
180.63B
Trailing P/E
45.37
Forward P/E
33.00
PEG Ratio (5yr expected)
2.94
Price/Sales (ttm)
7.77
Price/Book (mrq)
3.43
Enterprise Value/Revenue
7.61
Enterprise Value/EBITDA
24.76
Financial Highlights
Profitability and Income Statement
Profit Margin
18.55%
Return on Assets (ttm)
3.86%
Return on Equity (ttm)
7.76%
Revenue (ttm)
23.74B
Net Income Avi to Common (ttm)
4.07B
Diluted EPS (ttm)
5.07
Balance Sheet and Cash Flow
Total Cash (mrq)
7.03B
Total Debt/Equity (mrq)
36.04%
Levered Free Cash Flow (ttm)
4.86B
Company Insights: DAP.DE
DAP.DE does not have Company Insights